Literature DB >> 16370938

Single nucleotide polymorphisms in human P-glycoprotein: its impact on drug delivery and disposition.

Surajit Dey1.   

Abstract

Drug efflux pumps belong to a large family of ATP-binding cassette transporter proteins. These pumps bind their substrate and export it through the membrane using energy derived from ATP hydrolysis. P-glycoprotein, the main efflux pump in this family, is expressed not only in tumour cells but also in normal tissues with excretory function (liver, kidney and the intestine). It has a broad specificity of substrates and plays an important role in drug delivery and disposition. Recently, genetic screening of P-glycoprotein has yielded multiple single nucleotide polymorphisms, which seem to alter transporter function and expression. This review discusses the various polymorphisms of this gene and its impact on drug disposition and diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16370938     DOI: 10.1517/17425247.3.1.23

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  8 in total

1.  Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).

Authors:  Laura M Hodges; Svetlana M Markova; Leslie W Chinn; Jason M Gow; Deanna L Kroetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-03       Impact factor: 2.089

2.  Racial susceptibility for QT prolongation in acute drug overdoses.

Authors:  Alex F Manini; Barry Stimmel; David Vlahov
Journal:  J Electrocardiol       Date:  2013-12-04       Impact factor: 1.438

3.  Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury.

Authors:  J'mir L Cousar; Yvette P Conley; F Anthony Willyerd; Ajit A Sarnaik; Ava M Puccio; Philip E Empey; Patrick M Kochanek; Michael J Bell; David O Okonkwo; Robert S B Clark
Journal:  Neurocrit Care       Date:  2013-10       Impact factor: 3.210

4.  ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial.

Authors:  Roya Rafiee; Lata Chauhan; Todd A Alonzo; Yi-Cheng Wang; Ahlam Elmasry; Michael R Loken; Jessica Pollard; Richard Aplenc; Susana Raimondi; Betsy A Hirsch; Irwin D Bernstein; Alan S Gamis; Soheil Meshinchi; Jatinder K Lamba
Journal:  Blood Cancer J       Date:  2019-05-21       Impact factor: 11.037

5.  Genetic and non-genetic determinants of raltegravir penetration into cerebrospinal fluid: a single arm pharmacokinetic study.

Authors:  Daniel H Johnson; Deborah Sutherland; Edward P Acosta; Husamettin Erdem; Danielle Richardson; David W Haas
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

6.  ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib.

Authors:  Douglas Vivona; Luciene Terezina Lima; Alice Cristina Rodrigues; Carolina Tosin Bueno; Greyce Kelly Steinhorst Alcantara; Luiza Saldanha Ribeiro Barros; Vania Tiestsche DE Moraes Hungria; Carlos Sérgio Chiattone; Maria DE Lourdes Lopes Ferrari Chauffaille; Elvira Maria Guerra-Shinohara
Journal:  Oncol Lett       Date:  2014-02-07       Impact factor: 2.967

7.  Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States.

Authors:  Kerry Murphy; Donald R Hoover; Qiuhu Shi; Mardge Cohen; Monica Gandhi; Elizabeth T Golub; Deborah R Gustafson; Celeste Leigh Pearce; Mary Young; Kathryn Anastos
Journal:  AIDS       Date:  2013-09-24       Impact factor: 4.177

Review 8.  Perplexing Role of P-Glycoprotein in Tumor Microenvironment.

Authors:  Kianna Robinson; Venkataswarup Tiriveedhi
Journal:  Front Oncol       Date:  2020-03-05       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.